Provider Resources

THIRD-PARTY RESOURCES

These links provide recommendations for HCV management.

The below links to third-party content are provided as a convenience. AbbVie makes no representations as to the accuracy of their content and their inclusion is not an endorsement of those organizations by AbbVie or by those organizations of AbbVie or this website.

HCV Epidemiology

CDC
CDC Division of Viral Hepatitis (DVH) Strategic Plan
HHS National Viral Hepatitis Action Plan
HIV and Viral Hepatitis
Hepatitis B

HCV Screening and Diagnosis

Risk Factors and Guidelines for HCV Infection

CDC
AASLD/IDSA
USPSTF
CDC Testing Sequence Flow Chart
HCV in Pregnancy

Pretreatment Assessment

AASLD/IDSA Monitoring Recommendations
Clinical Calculators

Fibrosis-4 (FIB-4)

Child-Turcotte-Pugh (CTP)

AST to Platelet Ratio Index (APRI)

Model For End-Stage Liver Disease (MELD) for ages 12 and older

AUDIT Alcohol Consumption Questions (AUDIT‑C)

CAGE Questionnaire for Detecting Alcoholism

Patient Readiness for HCV Treatment

Substance Abuse and Mental Health Services Administration
Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment (PREP-C)

HCV Monitoring and Follow-up

AASLD/IDSA Recommendations

These guidelines contain information about diagnosing and on-treatment monitoring, including considerations in specific populations such as patients with advanced liver disease, HCV/HIV-1 coinfection, people who use drugs, transplant recipients, and those who may qualify for management with a simplified treatment algorithm

AASLD/IDSA Posttreatment Follow-up

These guidelines contain information on posttreatment follow-up for patients who achieved a sustained virologic response (SVR)* and patients who failed to achieve SVR

Harm Reduction Resources

CDC: Determination of Need for Syringe Services Programs
American Society of Addiction Medicine (ASAM)
CDC: People Who Inject Drugs and Viral Hepatitis

Patient Resources: Resources that providers can use during consultation with patients

CDC Patient Education Resources
Hepatitis C Basics for People Who Use Drugs Brochure

Additional Support

CDC Helpful Links
Hepatitis C Community Navigation Model and Toolkit
American Liver Foundation
HCP Finder

Find other healthcare professionals who treat HCV

*Sustained virologic response (SVR12), defined as HCV RNA less than the lower limit of quantification at 12 weeks after the end of treatment.

AASLD=American Association for the Study of Liver Diseases; AST=aspartate aminotransferase; CAGE=mnemonic for "cut, annoyed, guilty, eye opener;" CDC=Centers for Disease Control and Prevention; HHS=US Department of Health & Human Services; HIV=human immunodeficiency virus; IDSA=Infectious Diseases Society of America; USPSTF=US Preventive Services Task Force.